^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersBIOMARKER:
KRAS mutation + CDK9 overexpression + HR positive
i
Other names: KRAS, KRAS proto-oncogene GTPase, KRAS1, KRAS2, NS, NS3, OES, CFC2, RALD, K-Ras, RASK2, KI-RAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras 2, C-K-RAS, c-Ki-ras, c-Ki-ras2, Kirsten rat sarcoma viral oncogene homolog, CDK9, Cyclin Dependent Kinase 9, TAK, Tat-Associated Kinase Complex Catalytic Subunit, Cell Division Cycle 2-Like Protein Kinase 4, Cell Division Protein Kinase 9, Cyclin-Dependent Kinase 9, PITALRE, CDC2L4, C-2k, Cyclin-Dependent Kinase 9 (CDC2-Related Kinase), Serine/Threonine Protein Kinase PITALRE, Serine/Threonine-Protein Kinase PITALRE, CDC2-Related Kinase, CTK1, C-2K, ESR1, Era, ESR, NR3A1, ER, ER beta, PGR, Progesterone receptor, Nuclear receptor subfamily 3 group C member 3, NR3C3
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related biomarkers:
›
